Chris J. Hamilton, Stanley M. Roberts and Alexander Shipitsin
The newly synthesised Pβ,–Pγ-difluoromethylenebisphosphonate analogue 2 of nor-carbovir triphosphate is a potent inhibitor of HIV reverse transcriptase; it also exhibits a greatly enhanced stability to dephosphorylation, in foetal blood serum, relative to AZTTP and other nucleoside triphosphates.
O); λmax(H2O)/nm 252.0;
δH(400 MHz, D2O) 1.89 (1 H, dt, J 15.6, 4.4, 5′-βH), 2.97 (1 H, dt, J 14.0,
7.2, 5′-αH), 3.84 (2 H, d, J 9.2, PCH2), 4.76–4.81 (1 H, br, 4′-H),
5.28–5.0 (1 H, br, 1′-H), 6.07–6.11 (1 H, m, 2′-H), 6.33–6.38 (1 H, m,
3′-H), 7.75–7.87 (1 H, br, 8-H); δF(376 MHz, D2O) 42.40–42.90 (br,
CF2); δP(162 MHz, D2O)–1.69 (br, Pβ), 3.90 (br, Pγ), 11.44 (d, J 31.0,
Pα); m/z(ES) 522 (6%, MH+), 328 (15, M – CH2F2O4P2). For 3:
νmax(KBr)/cm–1 1236 (P
O); δP(162 MHz, D2O) 2.44 (br, Pβ), 9.61 (br,
Pγ), 10.34 (d, J 29.0, Pα); m/z(ES) 504 (57%, MH+), 328 (100, M –
CFH3O4P2). For 4: νmax(KBr)/cm–1 1216 (P
O); δP(162 MHz, D2O)
15.97 (1P, br, Pβ), 10.08 (2P, br, Pα and Pγ); m/z(ES) 486 (35%, MH+),
328 (100, M – CH4O4P2).